Research ArticleArticle
Open Access
Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study
Arthur Kavanaugh, Iain B. McInnes, Philip J. Mease, Stephen Hall, Hector Chinoy, Alan J. Kivitz, Zailong Wang and Shephard Mpofu
The Journal of Rheumatology September 2016, 43 (9) 1713-1717; DOI: https://doi.org/10.3899/jrheum.160275
Arthur Kavanaugh
From the University of California-San Diego, School of Medicine, LaJolla, California,
USA; Immunology, Infection and Inflammation, University of Glasgow, Glasgow,
UK; Swedish Medical Centre, and University of Washington School of Medicine, Seattle, Washington,
USA; Monash University, Melbourne,
Australia; UK National Institute for Health Research (NIHR) Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals National Health Service NHS Foundation Trust, University of Manchester,
UK; Altoona Center for Clinical Research, Duncansville, Pennsylvania; Novartis Pharmaceuticals Corp., East Hanover, New Jersey,
USA; Novartis Pharma AG, Basel,
Switzerland.
Iain B. McInnes
Philip J. Mease
Stephen Hall
Hector Chinoy
Alan J. Kivitz
Zailong Wang
Data supplements
Data Supplement
Data Supplement
Files in this Data Supplement:
- Data Supplement - Data Supplement
In this issue
The Journal of Rheumatology
Vol. 43, Issue 9
1 Sep 2016
Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study
Arthur Kavanaugh, Iain B. McInnes, Philip J. Mease, Stephen Hall, Hector Chinoy, Alan J. Kivitz, Zailong Wang, Shephard Mpofu
The Journal of Rheumatology Sep 2016, 43 (9) 1713-1717; DOI: 10.3899/jrheum.160275
Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study
Arthur Kavanaugh, Iain B. McInnes, Philip J. Mease, Stephen Hall, Hector Chinoy, Alan J. Kivitz, Zailong Wang, Shephard Mpofu
The Journal of Rheumatology Sep 2016, 43 (9) 1713-1717; DOI: 10.3899/jrheum.160275